STAAR Surgical (STAA) Tops Q1 EPS by 11c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y
May 5, 2021 4:01 PM EDTFirst Quarter ICL Sales Up 58% Y/Y and Units Up 54% Y/Y
Announces Submission of Clinical Trial Data to U.S. FDA for EVO Family of Myopia Lenses
Introduces Net Sales Outlook of Approximately $215 Million to $217 Million for Full Year 2021
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 2,... More
